Immunotherapy in NMSC: Challenges in CSCC and BCC

0.25 CME
0.25 CNE
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Doorway opens to staircase


Activity Release Date: January 16, 2023
Activity Expiration Date: January 15, 2024
Estimated time to complete activity: 15 minutes

Provider Statement

Provided by RMEI Medical Education, LLC


Target Audience

Medical oncology and dermatology clinicians

Activity Description

This 15-minute gamified activity features an interactive, escape-room approach to learning bite-sized information related to evidence-based strategies for integrating immunotherapy in the management of advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Assess current clinical evidence for immunotherapy-based treatment of advanced nonmelanoma skin cancer (NMSC)
  • Integrate immunotherapy in the management of advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC)


Khushalani Faculty Headshot
Nikhil I. Khushalani, MD (Chair)
Vice Chair and Senior Member
Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL

Disclosure of Financial Relationships

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.


Nikhil I. Khushalani, MD, has relevant financial relationships with Array BioPharma, AstraZeneca, Bristol Myers Squibb, Castle Biosciences, Genzyme, Immunocore, Incyte Corporation, Instil Bio, Iovance Biotherapeutics, Jounce Therapeutics, Merck, Nektar Therapeutics, Novartis, Pfizer, Regeneron (Advisor/Consultant); Bristol Myers Squibb, Celgene, Nektar Therapeutics, Regeneron, Replimune Group, Inc. (Other: Steering Committee); Amgen, Bristol Myers Squibb, Celgene, GlaxoSmithKline, HUYA Bioscience International, Merck, Modulation Therapeutics, Novartis, Regeneron, Replimune Group, Inc. (Research Funding); Amarin Pharmaceuticals, Asensus Surgical, Bellicum Pharmaceuticals (Stockholder).  

All of the relevant financial relationships listed for this individual have been mitigated according to RMEI policies.

Planners and Managers

RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.

Accreditation Statement

ACCME Jointly accredited In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education

RMEI Medical Education, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hour(s).

How to Participate in this Activity and Obtain CME Credit

In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 75% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at

Users must:

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation and attest to credit 

There is no fee to participate.

*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.

Rules and Regulations

This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Copyright Statement